2024: D. Jeff Keyser, RPh, JD, PhD
Dr. Keyser is President and CEO of Renibus Therapeutics, a clinical stage biopharmaceutical company dedicated to treating, improving, and extending patients’ lives by developing products to prevent disease progression, improve outcomes and protect against organ damage associated with cardio, renal and metabolic diseases. He is currently serving as the Chairman of the Board at Lantern Pharma.
He also co-founded ZS Pharma, which was acquired by AstraZeneca in 2015 for $2.7 billion. He invented the Mucinex product line for Adams Respiratory Therapeutics and developed and executed the R&D and Regulatory strategy for Adams Respiratory Therapeutics as Vice President of Development and Regulatory Affairs.